Zhang Ping, Zhuo Ling, Zou Yurong, Li Guisen, Peng Kun
Clin Nephrol. 2019 Aug;92(2):98-102. doi: 10.5414/CN109737.
gene mutations are known as the cause of Alport syndrome (AS), which typically manifests with hematuria, progressive renal failure, sensorineural hearing loss, and ocular abnormalities. Here we report a case of a 20-year-old male patient presenting with nephrotic syndrome who was diagnosed as having AS with focal segmental glomerulosclerosis (FSGS) lesion after the renal biopsy was performed. In this patient, the link between AS and FSGS lesion is complicated. Whole-exome sequencing was performed to identify its causal genetic variants, and the results revealed that AS with FSGS lesion is caused by mutation of the gene. gene mutations have phenotypic heterogeneity and thus, we suggest that genetic testing should be considered in such patients for accurate diagnosis and appropriate treatment.
基因突变被认为是奥尔波特综合征(AS)的病因,该综合征通常表现为血尿、进行性肾衰竭、感音神经性听力损失和眼部异常。在此,我们报告一例20岁男性肾病综合征患者,肾活检后被诊断为患有伴有局灶节段性肾小球硬化(FSGS)病变的AS。在该患者中,AS与FSGS病变之间的联系较为复杂。进行了全外显子组测序以确定其致病基因变异,结果显示伴有FSGS病变的AS是由该基因的突变引起的。基因突变具有表型异质性,因此,我们建议对此类患者考虑进行基因检测以实现准确诊断和恰当治疗。